1. Department of Pediatrics, Peking University Third Hospital, Beijing 100191, China;
2. Department of Neonatology, Women and Children's Hospital Affiliated to Xiamen University /Xiamen Maternal and Child Health Hospital, Xiamen, Fujian 361003, China;
3. Department of Neonatology, Pediatric Hospital of Fudan University, Shanghai 201102, China;
4. Department of Clinical Nutrition, Guangzhou Women & Children Medical Center, Guangzhou, Guangdong 510623, China;
5. Department of Neonatology, Children's Medical Center, Second Xiangya Hospital of Central South University, Changsha Hunan 410011, China;
6. Department of Neonatology, BaYi Children's Hospital, Seventh Medical Center of the Chinese people's Liberation Army, Beijing 100700, China
Abstract Metabolic bone disease of prematurity (MBDP) is a systemic bone disease with a reduction in bone mineral content due to disorder of calcium and phosphorus metabolism. There is still a lack of in-depth research and systematic understanding of MBDP in China, and there are many irregularities in clinical management of this disease. Based on relevant studies in China and overseas, Grading of Recommendations Assessment, Development and Evaluation was used to develop the expert consensus on the clinical management of MBDP, which provides recommendations from the following five aspects: high-risk factors, screening/diagnosis, prevention, treatment, and post-discharge follow-up of MBDP, so as to provide relevant practitioners with recommendations on the clinical management of MBDP to reduce the incidence rate of MBDP and improve its short- and long-term prognosis.
WU Xin-Ping, GU Chuan-Li, HAN Shu-Ping, DENG Xiao-Yi, CHEN Xiao-Qing, WANG Huai-Yan, LI Shuang-Shuang, WANG Jun, ZHOU Qin, HOU Wei-Wei, GAO Yan, HAN Liang-Rong, LIU Hong-Jie, YU Zhang-Bin, WANG Zeng-Qin, LI Na, LI Hai-Xin, ZHOU Jin-Jun, CHEN Shan-Shan, JIANG Shan-Yu, LU Xing-Xing, PAN Zhao-Jun, CHEN Xiao-Hui. A multicenter retrospective study on survival rate and complications of very preterm infants[J]. CJCP, 2021, 23(8): 814-820.